Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol

被引:77
作者
Guyot, M [1 ]
Fawaz, F [1 ]
机构
[1] Univ Bordeaux 2, Equipe Accueil EA525, Lab Pharm Galen & Biopharm, F-33076 Bordeaux, France
关键词
propranolol HCl; transdermal therapeutic system; hydroxypropylmethylcellulose; polyisobutylene; acrylic polymer; propylene glycol;
D O I
10.1016/S0378-5173(00)00494-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Propranolol hydrochloride, a water-soluble drug, was incorporated in three transdermal delivery systems using three polymers (hydroxypropylmethylcellulose, polyisobutylene and Ucecryl(R)MC808). The influence of different factors (polymeric material, matrix thickness, drug content, thickness of the adhesive layer and presence of a dissolution enhancer) was investigated. Microscopic observations and DSC thermograms have permitted to demonstrate that propranolol was essentially dissolved in the HPMC matrix and dispersed in the two other matrix types. In vitro dissolution study was carried out according to European Pharmacopoeia. Release from HPMC matrices without adhesive coating was fast. Release from these matrices became more regular (reduction of the burst effect) and slow when they are coated with a 12 mu m thick Ucecryl layer. Release from different PIE matrices was too slow to be suitable as TDDS for propranolol. The best release modulation was obtained from Ucecryl matrices. In all matrices types, propylene glycol accelerated propranolol release rate. The kinetic of drug release from most matrix types was more closely described by the square-root model (Higuchi). (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:171 / 182
页数:12
相关论文
共 26 条
[1]   EVALUATION OF DRUG-CONTAINING POLYMER-FILMS PREPARED FROM AQUEOUS LATEXES [J].
BODMEIER, R ;
PAERATAKUL, O .
PHARMACEUTICAL RESEARCH, 1989, 6 (08) :725-730
[2]   Structural parameters involved in the permeation of propranolol HCl by iontophoresis and enhancers [J].
Chesnoy, S ;
Durand, D ;
Doucet, J ;
Couarraze, G .
JOURNAL OF CONTROLLED RELEASE, 1999, 58 (02) :163-175
[3]   Therapeutic effect and pharmacokinetics of ketotifen transdermal delivery system [J].
Chiang, CH ;
Chen, JL ;
Liu, YT ;
Wang, DP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (03) :213-217
[4]   Design and evaluation of a lorazepam transdermal delivery system [J].
Costa, P ;
Ferreira, DC ;
Morgado, R ;
Lobo, JMS .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (10) :939-944
[5]  
DEMEY C, 1989, ARZNEIMITTEL-FORSCH, V39-2, P1505
[6]  
Dittgen M, 1997, STP PHARMA SCI, V7, P403
[7]   PROPRANOLOL HYDROCHLORIDE AND AMINOPHYLLINE RELEASE FROM MATRIX TABLETS CONTAINING HYDROXYPROPYLMETHYLCELLULOSE [J].
FORD, JL ;
RUBINSTEIN, MH ;
HOGAN, JE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 24 (2-3) :339-350
[9]   TRANSDERMAL PENETRATION ENHANCERS IN RABBIT PINNA SKIN - DURATION OF ACTION, SKIN IRRITATION, AND IN-VIVO IN-VITRO COMPARISON [J].
HIRVONEN, J ;
SUTINEN, R ;
PARONEN, P ;
URTTI, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 99 (2-3) :253-261
[10]   Experimental verification of the mechanistic model for transdermal transport including iontophoresis [J].
Hirvonen, J ;
Murtomäki, L ;
Kontturi, K .
JOURNAL OF CONTROLLED RELEASE, 1998, 56 (1-3) :169-174